Pierrot Harvie

1.5k total citations
25 papers, 1.2k citations indexed

About

Pierrot Harvie is a scholar working on Molecular Biology, Biomaterials and Infectious Diseases. According to data from OpenAlex, Pierrot Harvie has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Biomaterials and 5 papers in Infectious Diseases. Recurrent topics in Pierrot Harvie's work include RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Nanoparticle-Based Drug Delivery (6 papers). Pierrot Harvie is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Nanoparticle-Based Drug Delivery (6 papers). Pierrot Harvie collaborates with scholars based in Canada, United States and Sweden. Pierrot Harvie's co-authors include Marcel B. Bally, Frances M. P. Wong, Lawrence D. Mayer, Sharon A. Johnstone, Paul Tardi, Natashia Harasym, Troy O. Harasym, David Bermudes, Natalia Zisman and Sherwin Xie and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Advanced Drug Delivery Reviews.

In The Last Decade

Pierrot Harvie

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierrot Harvie Canada 15 833 282 220 154 106 25 1.2k
Kelsey L. Swingle United States 19 1.1k 1.3× 219 0.8× 200 0.9× 248 1.6× 40 0.4× 24 1.5k
Milan Fábry Czechia 21 750 0.9× 69 0.2× 156 0.7× 78 0.5× 24 0.2× 82 1.3k
Makan Khoshnejad United States 13 410 0.5× 157 0.6× 52 0.2× 100 0.6× 76 0.7× 20 689
Eva Åkerblom Sweden 19 430 0.5× 164 0.6× 43 0.2× 59 0.4× 62 0.6× 49 1.3k
Timothy M. Jacobs United States 13 505 0.6× 144 0.5× 77 0.3× 112 0.7× 27 0.3× 28 812
Caroline Lonez Belgium 23 971 1.2× 93 0.3× 206 0.9× 192 1.2× 90 0.8× 57 1.7k
Naroa Serna Spain 22 914 1.1× 310 1.1× 86 0.4× 165 1.1× 32 0.3× 62 1.4k
Fangfang Chen China 14 329 0.4× 266 0.9× 46 0.2× 155 1.0× 44 0.4× 27 880
Marc Van Regenmortel France 8 797 1.0× 64 0.2× 73 0.3× 160 1.0× 93 0.9× 9 1.6k
Sandra K. Klimuk Canada 12 806 1.0× 294 1.0× 67 0.3× 138 0.9× 14 0.1× 14 1.1k

Countries citing papers authored by Pierrot Harvie

Since Specialization
Citations

This map shows the geographic impact of Pierrot Harvie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierrot Harvie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierrot Harvie more than expected).

Fields of papers citing papers by Pierrot Harvie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierrot Harvie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierrot Harvie. The network helps show where Pierrot Harvie may publish in the future.

Co-authorship network of co-authors of Pierrot Harvie

This figure shows the co-authorship network connecting the top 25 collaborators of Pierrot Harvie. A scholar is included among the top collaborators of Pierrot Harvie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierrot Harvie. Pierrot Harvie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Samuel, Richard S. Young, Michael J. Kerin, et al.. (2024). STRATEGIES FOR PRODUCING CLINICAL AND COMMERCIAL RNA-LNP DRUG PRODUCTS. Cytotherapy. 26(6). S147–S147. 4 indexed citations
2.
Balgi, Aruna D., et al.. (2024). HIGH THROUGHPUT SCREENING OF LIPID NANOPARTICLES FOR ENHANCED DRUG DELIVERY TO IMMUNE CELLS. Cytotherapy. 26(6). S144–S144. 1 indexed citations
3.
Prieve, Mary, Pierrot Harvie, Sean Monahan, et al.. (2018). Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency. Molecular Therapy. 26(3). 801–813. 115 indexed citations
4.
Vaish, Narendra K., Feng Chen, Shaguna Seth, et al.. (2010). Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs. Nucleic Acids Research. 39(5). 1823–1832. 83 indexed citations
5.
Tardi, Paul, Sharon A. Johnstone, Natashia Harasym, et al.. (2008). In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. Leukemia Research. 33(1). 129–139. 288 indexed citations
6.
Johnstone, Sharon A., Pierrot Harvie, Salam Kadhim, et al.. (2005). Synergistic antitumor activity observed for a fixed ratio liposome formulation of Cytarabine (Cyt):Daunorubicin (Daun) against preclinical leukemia models. Cancer Research. 65. 329–329. 3 indexed citations
7.
Ramsay, Euan, Malathi Anantha, Awa Dicko, et al.. (2004). A novel approach to prepare a liposomal irinotecan formulations that exhibit significant therapeutic activity in vivo. Cancer Research. 64. 148–148. 1 indexed citations
8.
Wong, Frances M. P., et al.. (2003). Phosphatidylethanolamine mediated destabilization of lipid-based pDNA delivery systems. International Journal of Pharmaceutics. 255(1-2). 117–127. 5 indexed citations
9.
Bruckheimer, Elizabeth, et al.. (2003). In vivo efficacy of folate-targeted lipid–protamine–DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma. Cancer Gene Therapy. 11(2). 128–134. 18 indexed citations
10.
Wasan, Ellen K., Dorothy L. Reimer, Pierrot Harvie, et al.. (2003). Targeted Gene Transfer: A Practical Guide Based on Experience with Lipid-Based Plasmid Delivery Systems. Humana Press eBooks. 25. 255–304. 1 indexed citations
11.
Harvie, Pierrot, et al.. (2003). Targeting of Lipid-Protamine-DNA (LPD) Lipopolyplexes Using RGD Motifs. Journal of Liposome Research. 13(3-4). 231–247. 35 indexed citations
12.
Harvie, Pierrot, et al.. (2000). Use of Poly(ethylene glycol)–Lipid Conjugates to Regulate the Surface Attributes and Transfection Activity of Lipid–DNA Particles. Journal of Pharmaceutical Sciences. 89(5). 652–663. 138 indexed citations
13.
Wasan, Ellen K., Pierrot Harvie, Katarina Edwards, Göran Karlsson, & Marcel B. Bally. (1999). A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1461(1). 27–46. 36 indexed citations
14.
Bally, Marcel B., Pierrot Harvie, Frances M. P. Wong, et al.. (1999). Biological barriers to cellular delivery of lipid-based DNA carriers. Advanced Drug Delivery Reviews. 38(3). 291–315. 142 indexed citations
15.
Muyombwe, Anthony, Martin Olivier, Pierrot Harvie, et al.. (1998). Protection againstLeishmania majorChallenge Infection in Mice Vaccinated with Live Recombinant Parasites Expressing a Cytotoxic Gene. The Journal of Infectious Diseases. 177(1). 188–195. 31 indexed citations
16.
Harvie, Pierrot, Frances M. P. Wong, & Marcel B. Bally. (1998). Characterization of Lipid DNA Interactions. I. Destabilization of Bound Lipids and DNA Dissociation. Biophysical Journal. 75(2). 1040–1051. 73 indexed citations
17.
Omar, Rabeea F., Pierrot Harvie, Pierrette Gourde, et al.. (1997). Antiviral Efficacy and Toxicity of Ribavirin and Foscarnet Each Given Alone or in Combination in the Murine AIDS Model. Toxicology and Applied Pharmacology. 143(1). 140–151. 5 indexed citations
18.
Harvie, Pierrot, Rabeea F. Omar, Nathalie Dusserre, et al.. (1996). Antiviral Efficacy and Toxicity of Ribavirin in Murine Acquired Immunodeficiency Syndrome Model. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(5). 451–461. 14 indexed citations
19.
Harvie, Pierrot, André Désormeaux, Michel J. Tremblay, et al.. (1995). Lymphoid tissues targeting of liposome-encapsulated 2/,3/-dideoxyinosine. AIDS. 9(7). 701–708. 27 indexed citations
20.
Désormeaux, André, Pierrot Harvie, Denis Beauchamp, et al.. (1994). Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2',3'-dideoxyinosine. AIDS. 8(11). 1545–1554. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelsey L. Swingle Breakdown of academic impact, for papers by Milan Fábry Breakdown of academic impact, for papers by Makan Khoshnejad Breakdown of academic impact, for papers by Eva Åkerblom Breakdown of academic impact, for papers by Timothy M. Jacobs Breakdown of academic impact, for papers by Caroline Lonez Breakdown of academic impact, for papers by Naroa Serna Breakdown of academic impact, for papers by Fangfang Chen Breakdown of academic impact, for papers by Marc Van Regenmortel Breakdown of academic impact, for papers by Sandra K. Klimuk
Rankless by CCL
2026